STOCK TITAN

UnitedHealth (UNH) director McNabb adds 53 shares via dividend equivalents

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

UnitedHealth Group director reports small stock accrual from dividends

A UnitedHealth Group Inc. director, Frederick William McNabb III, reported receiving 53 shares of UnitedHealth Group common stock on 12/16/2025. The filing states these shares represent dividend equivalents paid on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units. The transaction was recorded at a price of $0 per share, reflecting that no cash was paid by the director for these shares.

Following this transaction, the director beneficially owns 14,394 shares of UnitedHealth Group common stock in direct ownership. The form was filed as a single-reporting-person Form 4 and signed by an attorney-in-fact on behalf of the director.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MCNABB FREDERICK WILLIAM III

(Last) (First) (Middle)
C/O UNITEDHEALTH GROUP INCORPORATED
1 HEALTH DRIVE

(Street)
EDEN PRAIRIE MN 55344

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/16/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/16/2025 A 53(1) A $0 14,394 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.
Remarks:
Faraz A. Choudhry, Attorney-in-Fact for Frederick William McNabb III 12/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UnitedHealth Group (UNH) report for Frederick William McNabb III?

The filing shows that director Frederick William McNabb III received 53 shares of UnitedHealth Group common stock as dividend equivalents on vested deferred stock units on 12/16/2025.

Did the UnitedHealth Group (UNH) director pay for the 53 shares reported in this Form 4?

No cash was paid for these shares. The filing lists a transaction price of $0 per share because they were issued as dividend equivalents on vested deferred stock units.

How many UnitedHealth Group (UNH) shares does the director own after this transaction?

After receiving the 53 dividend-equivalent shares, the director beneficially owns 14,394 shares of UnitedHealth Group common stock in direct ownership.

What is the nature of the dividend equivalents reported for UnitedHealth Group (UNH)?

The filing explains that the 53 shares represent dividend equivalents paid on vested deferred stock units. These dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units.

What is the reporting person’s relationship to UnitedHealth Group (UNH)?

The reporting person is identified as a Director of UnitedHealth Group Inc. This relationship is marked in the filing under the section for the reporting person’s connection to the issuer.

Is the UnitedHealth Group (UNH) Form 4 filed by more than one reporting person?

No. The document indicates that the Form 4 is filed by one reporting person, not by a group or multiple filers.

Who signed the UnitedHealth Group (UNH) Form 4 for this insider transaction?

The Form 4 was signed by Faraz A. Choudhry as Attorney-in-Fact for Frederick William McNabb III on 12/18/2025.

Unitedhealth Gp

NYSE:UNH

UNH Rankings

UNH Latest News

UNH Latest SEC Filings

UNH Stock Data

307.04B
898.46M
0.82%
86.64%
1.32%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
EDEN PRAIRIE